KST Pharma SRL
0.3 FTEKST Pharma reported total assets of 168,506 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 May 2026), with 0.3 full-time equivalent.
The score of KST Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -80 % Total assets -30 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
KST Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 25 May 2022
KST Pharma's financial analysis
- Solvency12.5%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KST Pharma
KST Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0647.823.210
- VAT number
- BE0647823210
- Peppol
- Registered · 0208:0647823210 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Feb 2016
- Registered office
- 7972 Beloeil
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
KST Pharma (SRL) has been based in Beloeil since 2016, active in: business and other management consultancy activities. For 2025, it reports a net profit of 140 € and equity of 21,112 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 12.5%, below the median of its sector (50.1%).
Companies similar to KST Pharma
Companies in the same business, of comparable size and area, outside its group.
- AURA Business and other management consultancy activities Kruisem · balance sheet 168,508 €
- Fidacco Business and other management consultancy activities Duffel · balance sheet 168,564 €
- Rex Consult Business and other management consultancy activities Hasselt · balance sheet 168,433 €
- Michel Sobczak Business and other management consultancy activities Chaudfontaine · balance sheet 168,404 €
- Green Dot Business and other management consultancy activities Verviers · balance sheet 168,612 €
- Arise & Victor-E Business and other management consultancy activities Hannut · balance sheet 168,641 €
- International Consulting AND Administration Business and other management consultancy activities Grobbendonk · balance sheet 168,651 €
- VAE Solis Europe Business and other management consultancy activities Schaerbeek · balance sheet 168,359 €
Frequently asked questions about KST Pharma
What is the revenue of KST Pharma?
KST Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KST Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0647823210 for KST Pharma, if the company is VAT-registered. Its company number (CBE) is 0647.823.210.
Where is the registered office of KST Pharma?
According to the CBE register, the registered office of KST Pharma is in 7972 Beloeil.
What is the equity of KST Pharma?
At the close of the 2025 financial year, the equity of KST Pharma amounts to 21,112 €, a solvency of 12.5% of total assets.
How many people work at KST Pharma?
0.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages KST Pharma?
The register lists 1 active mandates at KST Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KST Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →